Boursorama interview of Alain Moussy, CEO of AB Science
23/12/2020 – Read the interview of Alain Moussy, CEO of AB Science, in Boursorama
23/12/2020 – Read the interview of Alain Moussy, CEO of AB Science, in Boursorama
21/12/2020 – AB Science announces today the success of its capital raise for a total amount of 15 million euros
18/12/2020 – AB Science communicates the results from phase 2B/3 study evaluating masitinib in Alzheimer’s disease
17/12/2020 – Presentation of the webcast held on December 17, 2020 on masitinib in Alzheimer’s Disease
17/12/2020 – AB Science provides the results of the Extraordinary Shareholders’ Meeting of December 16, 2020
17/12/2020 – AB Science issues a corrective press release regarding adverse events information from study AB09004 reported on December 16, 2020